Showing results (441-450 of 454) with videos related to

Sort By:
Pageof 46
Molecular Cancer Therapeutics|September 4, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase ActivationFeven Tameire, Paulina Wojnarowicz, Crissy Dudgeon, et al.
Molecular Cancer Therapeutics|August 20, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2 Targeting Agents Results from Kinase ActivationFeven Tameire, Paulina Wojnarowicz, Crissy Dudgeon, et al.
Tissue Antigens|March 11, 2004
Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I lociK Cao, A M Moormann, K E Lyke, et al.
Nature Communications|January 3, 2024
Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activitySheng Wang, Sebastian O Klein, Sylvia Urban, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 3, 2022
Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder: CIAO-II studyPhilip J Asherson, Lena Johansson, Rachel Holland, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Transaminases Provide Key Chiral Building Blocks for the Synthesis of Selective M1/M4 AgonistsChristopher G Thomson, Kelly Boss, Amy Calhoun, et al.
Journal of Medicinal Chemistry|March 26, 2024
Discovery of HC-7366: An Orally Bioavailable and Efficacious GCN2 Kinase ActivatorChristopher G Thomson, Thomas D Aicher, Weiwei Cheng, et al.
Journal of the South African Veterinary Association|October 19, 2007
Building capacity for improved veterinary epidemiosurveillance in southern AfricaC Bamhare, G Thomson, A Latif, et al.
The Journal of Rheumatology|December 3, 2016
Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in CanadaClaire E H Barber, Lauren Jewett, Elizabeth M Badley, et al.
Journal of Medicinal Chemistry|August 10, 2016
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial HypertensionDuncan E Shaw, Ferheen Baig, Ian Bruce, et al.
Pageof 46